Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative therapies operate by mimicking the natural actions of GLP-1, a hormone secreted by the https://iowa-bookmarks.com/story16614983/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes